Catalent | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Agilent USD 6.14B 109M 2025-04
AstraZeneca USD 41.04B 168M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Bruker USD 1.83B 35.8M 2025-03
Centene USD 27.92B 1.51B 2025-03
Charles River Laboratories USD 3.19B 267.17M 2025-03
Cigna USD 40.23B 807M 2025-03
Danaher USD 50.85B 1.31B 2025-03
Dentsply International USD 2.01B 68M 2025-03
Elevance Health USD 42.5B 1.19B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Hologic USD 4.62B 154.6M 2025-03
Humana USD 17.75B 1.38B 2025-03
Illumina USD 2.37B 5M 2025-03
Intuitive Surgical USD 17.21B 678.1M 2025-03
IQVIA Holdings USD 5.98B 90M 2025-03
J&J USD 78.11B 6.62B 2025-03
Laboratory Of America USD 8.32B 269.5M 2025-03
Lonza CHF 9.33B 23M 2024-12
McKesson USD -2074000000 1.01B 2025-03
Merck EUR 29.9B 89M 2025-03
Merck USD 48.34B 2.02B 2025-03
Mettler Toledo International USD -181982000 55.09M 2025-03
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Quest Diagnostics USD 6.93B 151M 2025-03
Repligen USD 1.99B 12.76M 2025-03
Revvity USD 7.64B 29.74M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
Thermo Fisher Scientific USD 49.36B 227M 2025-03
UnitedHealth USD 100.81B 8.15B 2025-03
Waters USD 1.96B 133.89M 2025-03
West Pharmaceutical Services USD 2.68B 800K 2025-03



Catalent Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.